Veterinary Vaccines Market will rise to US$11.40 Billion by 2024

The global veterinary vaccines market is highly consolidated, with the top five vendors accounting for a share of nearly 65% in the overall market in 2015, reports TMR in a new study. Zoetis, Inc., Merck & Co., and Sanofi Aventis, the top three companies in the market collectively held a share of more than 45% of the overall market in the same year.

Targeted in-licensing and acquisitions, expansion of global manufacturing and supply capacities, and increased investments towards research and development activities are some of the key strategies adopted by leading vendors in the market. A recent instance is the strategic alliance of Sanofi with Boehringer Ingelheim in June 2016. Under this alliance, an exchange of Boehringer Ingelheim’s consumer healthcare (CHC) unit with Sanofi’s animal health business took place.

In the past few years, factors such as globalization and intense changes in global climate have led to a vast rise in the prevalence of zoonotic diseases globally. To prevent the huge loss of livestock and potential threat to human lives that global outbreaks of several zoonotic diseases cause, there has been a surge in government initiatives aimed at mandating vaccination for companion and farm animals. Active efforts are also undertaken by government and non-government bodies to increase awareness among pet and livestock owners about rampant and hazardous animal diseases, their symptoms, and medication.

This 185 page report gives readers a comprehensive overview of the Veterinary Vaccines Market. Browse through 24 data tables and 50 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/veterinary-vaccines-market.html

Also, the vast surge in the global demand for meat, chicken, eggs, and milk is compelling livestock farmers to pay proper attention to vaccination to ensure the production excellent quality products and thereby keep their businesses sustainable and profitable. In the past few years, pet ownership and the money spent for ensuring health and wellness of companion animals has significantly increased on a global front. According to the national pet owners’ survey of 2015-2016, 65% households in the U.S. own a pet. The pet industry in the U.S. had a valuation of US$ 60.59 bn in 2015 and is expected to rise to US$62.75 bn in 2016.

These factors are collectively expected to have a significant impact on the overall development of the global veterinary vaccines market in the next few years. Moreover, the market is also expected to benefit enormously from the vast rise in research and development activities and increased demand for advanced and more effective veterinary vaccines across the globe.

National governments play a key role in deciding the profitability of the veterinary vaccines market. For instance, the Government of India purchases foot-and-mouth disease (FMD) vaccines in bulk from manufacturers and supplies it to different parts of the country. Such bilk purchases result in reduced prices of the vaccines, substantially bringing down the profitability of manufacturers.

Get accurate market forecast and analysis on the Veterinary Vaccines Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215

The short product exclusivity period in the animal healthcare industry, of nearly 3-5 years results in intense competition from cheaper generic substitutes and over-the-counter products. Additionally, strict regulations for product approval and the resulting decline in the number of products that can enter the market limit the overall profitability of the global veterinary vaccines market substantially.

The global market for veterinary vaccines is expected to expand at a healthy 6.9% CAGR over the period between 2016 and 2024. The market, which had a valuation of US$6,271.8 mn in 2015, is expected to rise to US$11,403.6 mn by 2024. In terms of technology type, the segment of live attenuated vaccines is presently the leading contributor to market’s overall revenues. The segment accounted for over 44% in the global market in 2015. Geography-wise, North America held nearly 37% of the global market’s overall revenues in 2015.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.